Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.

Abstract

INTRODUCTION CC chemokine receptor 2 (CCR2) is a key mediator of the activation and migration of inflammatory monocytes. As such, it has been investigated extensively as a target for therapeutic intervention in a diverse range of diseases. AREAS COVERED This article reviews both the patent and peer-reviewed literature on the discovery of CCR2 antagonists… (More)
DOI: 10.1517/13543776.2013.771168

Topics

Cite this paper

@article{Carter2013ProgressIT, title={Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.}, author={Percy H. Carter}, journal={Expert opinion on therapeutic patents}, year={2013}, volume={23 5}, pages={549-68} }